Sildenafil citrate and uteroplacental perfusion in fetal growth restriction
Egyptian Journal of Hospital Medicine [The]. 2018; 71 (4): 2989-2995
Dans Anglais
| IMEMR
| ID: emr-192557
ABSTRACT
Background:
Severe early-onset fetal growth restriction can lead to a range of adverse outcomes including fetal or neonatal death, neurodisability, and lifelong risks to the health of the affected child. Sildenafil, a phosphodiesterase type 5 inhibitor, potentiates the actions of nitric oxide, which leads to vasodilatation of the uterine vessels and might improve fetal growth in utero
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Perfusion
/
Grossesse
/
Études prospectives
/
Circulation placentaire
/
Femmes enceintes
/
Retard de croissance intra-utérin
Type d'étude:
Essai clinique contrôlé
Limites du sujet:
Adulte
/
Femelle
/
Humains
langue:
Anglais
Texte intégral:
Egypt. J. Hosp. Med.
Année:
2018
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS